A report outlining Almac Diagnostic's new prognostic test to determine the risk of colon cancer recurrence was published in the online version of the Journal of Clinical Oncology.
The test included 73 patients with recurrent disease and 142 patients with no recurrence within 5 years of surgery. Researchers developed a gene signature, and in tests, the signature identified high-risk patients with a hazard ration of 2.62.
Related Articles on Colorectal Cancer:
Study: Poor Men More Likely to Die of Colorectal Cancer
Screening Baby Boomers for Hepatitis C During a Routine Colon Cancer Screening
Current, Former Smokers Face Elevated Colorectal Cancer Risk
The test included 73 patients with recurrent disease and 142 patients with no recurrence within 5 years of surgery. Researchers developed a gene signature, and in tests, the signature identified high-risk patients with a hazard ration of 2.62.
Related Articles on Colorectal Cancer:
Study: Poor Men More Likely to Die of Colorectal Cancer
Screening Baby Boomers for Hepatitis C During a Routine Colon Cancer Screening
Current, Former Smokers Face Elevated Colorectal Cancer Risk